297 related articles for article (PubMed ID: 31323869)
1. Advances in the Development of Antiviral Strategies against Parvovirus B19.
Manaresi E; Gallinella G
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of cidofovir on parvovirus B19 replication.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of brincidofovir on parvovirus B19.
Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Virus Res; 2016 Jul; 220():47-51. PubMed ID: 27071853
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
[TBL] [Abstract][Full Text] [Related]
7. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
Bieri J; Ros C
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3-(Imidazo[2,1-
Conti I; Morigi R; Locatelli A; Rambaldi M; Bua G; Gallinella G; Leoni A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875983
[TBL] [Abstract][Full Text] [Related]
9. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19.
Hu X; Jia C; Wu J; Zhang J; Jiang Z; Ma K
Front Cell Infect Microbiol; 2022; 12():916012. PubMed ID: 35795188
[TBL] [Abstract][Full Text] [Related]
10. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
Xu P; Ganaie SS; Wang X; Wang Z; Kleiboeker S; Horton NC; Heier RF; Meyers MJ; Tavis JE; Qiu J
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530599
[TBL] [Abstract][Full Text] [Related]
11. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
[TBL] [Abstract][Full Text] [Related]
12. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
Ganaie SS; Chen AY; Huang C; Xu P; Kleiboeker S; Du A; Qiu J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437973
[TBL] [Abstract][Full Text] [Related]
13. Human parvovirus B19: a review.
Acta Virol; ; . PubMed ID: 25283854
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
